Our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield has reaped a tremendous amount of fresh research. Many of these are currently in press, so you can find much of our work in its open access form via our institutional repository. Tuck in here.
Aber, A., Poku, E.,
Phillips, P., Essat, M., Buckley Woods, H., Palfreyman, S., Kaltenthaler, E.,
Jones, G., Michaels, J., 2017. Systematic review of patient-reported outcome
measures in patients with varicose veins. British Journal of Surgery. doi:10.1002/bjs.10639
 |
| © SAGE Journals |
Ali,
S., Tsuchiya, A., Asaria, M., Cookson, R., 2017. How Robust Are Value Judgments
of Health Inequality Aversion? Testing for Framing and Cognitive Effects. Medical Decision. Making. 37, 635–646. doi:10.1177/0272989X17700842
Aslam,
R.W., Hendry, M., Booth, A., Carter, B., Charles, J.M., Craine, N., Edwards,
R.T., Noyes, J., Ntambwe, L.I., Pasterfield, D., Rycroft-Malone, J., Williams,
N., Whitaker, R., 2017. Intervention Now to Eliminate Repeat Unintended
Pregnancy in Teenagers (INTERUPT): a systematic review of intervention
effectiveness and cost-effectiveness, and qualitative and realist synthesis of
implementation factors and user engagement. BMC Medicine 15, 155.
doi:10.1186/s12916-017-0904-7
Chambers,
D., Booth, A., Rodgers, M., Preston, L., Baxter, S., Dalton, J., Thomas, S.,
Johnson, M., Goyder, E., Parker, G., Street, A., Eastwood, A., 2017. NIHR
HS&DR evidence synthesis centres: achievements and learning from the first
three year programme, 2014–2017. NIHR Health Services and Delivery Research Programme,
Southampton.
Grimm,
S.E., Strong, M., Brennan, A., wailoo, A., n.d. The HTA Risk Analysis Chart:
Visualising the Need for and Potential Value of Managed Entry Agreements in
Health Technology Assessment. Pharmacoeconomics.
 |
| © Wiley |
Johannesen,
K.M., Claxton, K., Sculpher, M.J., Wailoo, A.J., n.d. How to design the
cost-effectiveness appraisal process of new healthcare technologies to maximise
population health: A conceptual framework. Health Economics. doi:10.1002/hec.3561
Keetharuth,
D., Brazier, J., Connell, J., Bjorner, J., Carlton, J., Taylor Buck, E.,
Ricketts, T., McKendrick, K., Browne, J., Croudace, T., Barkham, M., n.d.
Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure
for use with people experiencing mental health difficulties. British Journal of Psychiatry.
Lysdahl,
K.B., Mozygemba, K., Burns, J., Brönneke, J.B., Chilcott, J.B., Ward, S.,
Hofmann, B., 2017. Comprehensive assessment of complex technologies:
integrating various aspects in health technology assessment. International Journal of Technology Assessment in Health Care. doi:10.1017/S0266462317000678
Preston,
L.R., Chambers, D., Campbell, F., Cantrell, A., Turner, J., Goyder, E., 2017.
What evidence is there for the identification and management of frail older
people in the emergency department? A systematic mapping review. NIHR Journals
Library, Southampton.
 |
| © Springer Science |
Simpson,
E.L., Hock, E., Stevenson, M., Wong, R., Dracup, N., Wailoo, A., Conaghan,
P.G., Estrach, C., Edwards, C.J., Wakefield, R.J., n.d. What is the added value
of ultrasound joint examination for monitoring synovitis in rheumatoid
arthritis and can it be used to guide treatment decisions? A systematic review
and cost-effectiveness analysis. Health Technol. Assess.
Squires,
H., Pandor, A., Thokala, P., Stevens, J.W., Kaltenthaler, E., Clowes, M.,
Coleman, R., Wyld, L., 2017. Pertuzumab for the Neoadjuvant Treatment of
Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective
of a NICE Single Technology Appraisal. Pharmacoeconomics.
doi:10.1007/s40273-017-0556-7
Squires,
H.Y., Poku, E., Bermejo, I., Cooper, K., Stevens, J., Hamilton, J., Wong, R.,
Denniston, A., Pearce, I., Quhill, F., n.d. A systematic review and economic
evaluation of adalimumab and dexamethasone for treating non-infectious
intermediate, posterior or panuveitis in adults. Health Technol. Assess.